Number (%) unless otherwise stated | Mobile (N=644) | Standard (N=1497) | p Value |
---|---|---|---|
Delayed/immediate quit | |||
Delayed | 523 (81.2) | 1148 (76.7) | 0.02 |
Immediate | 121 (18.8) | 349 (23.3) | |
NRT used | |||
No | 64 (9.9) | 287 (19.2) | <0.001 |
Yes | 580 (90.1) | 1210 (80.8) | |
Varenicline used | |||
No | 567 (88.0) | 1209 (80.8) | |
Yes | 77 (12.0) | 288 (19.2) | <0.001 |
Number of contacts with advisor | |||
Median (IQR) | 2 (1–4) | 5 (3–7) | <0.001 |
Number of sessions attended | |||
Median (IQR) | 2 (1–4) | 4 (2–6) | <0.001 |
4-week self-reported abstinence* | |||
Lost to FU | 229 (35.6) | 247 (16.5) | <0.001 |
Not abstinent | 191 (29.7) | 488 (32.6) | |
Abstinent | 224 (34.8) | 762 (50.9) | |
4-week CO-validated abstinence* | |||
Lost to FU | 331 (51.4) | 497 (33.2) | <0.001 |
Not abstinent | 195 (30.3) | 499 (33.3) | |
Abstinent | 118 (18.3) | 501 (33.5) |
*If assume those lost to follow-up or missing are not abstinent, comparison of abstinent versus not abstinent p values same.
CO, carbon monoxide; FU, follow-up; NRT, nicotine replacement therapy; SSS, stop smoking service.